Obesity and related risk of myeloproliferative neoplasms among israeli adolescents

被引:16
作者
Leiba, Adi [1 ,2 ,3 ]
Duek, Adrian [2 ,4 ]
Afek, Arnon [2 ]
Derazne, Estela [2 ]
Leiba, Merav [2 ,4 ]
机构
[1] IDF Med Corps, Tel Hashomer, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[3] Harvard Med Sch, Dept Med, Mt Auburn Hosp, Cambridge, MA USA
[4] Sheba Med Ctr, Dept Hematol & Bone Marrow Transplant, Tel Hashomer, Israel
关键词
ESSENTIAL THROMBOCYTHEMIA; POLYCYTHEMIA-VERA; LIFE-STYLE; MYELOFIBROSIS; ADIPONECTIN;
D O I
10.1002/oby.21863
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveObesity has been associated with various malignancies, but a clear association between overweight and myeloproliferative neoplasms (MPN) has not been established. MethodsThis study assessed the association between adolescent obesity and future risk for MPN. Data on 2,516,256 Israeli adolescents, who underwent a compulsory general health examination at ages 16 to 19, between 1967 and 2011, were linked to the National Cancer Registry in this nationwide, population-based cohort study. Cox proportional hazards models were used to estimate the hazard ratio (HR) for MPN associated with BMI measured at adolescence. ResultsThe mean follow-up of 19.8612.15 years reflected 49,977,521 person years, during which 433 examinees developed MPN, primarily chronic myelogenous leukemia, polycythemia vera, and essential thrombocythemia. Obesity (BMI95th percentile) in adolescence significantly predicted increased risk of MPN with HR (adjusted for sex) of 1.81 (95% confidence interval 1.13-2.92, P=0.014). ConclusionsAdolescent obesity might be related to an increased incidence of myeloproliferative neoplasms.
引用
收藏
页码:1187 / 1190
页数:4
相关论文
共 20 条
  • [1] Environmental, lifestyle, and familial/ethnic factors associated with myeloproliferative neoplasms
    Anderson, Lesley A.
    Duncombe, Andrew S.
    Hughes, Maria
    Mills, Moyra E.
    Wilson, Jessica C.
    McMullin, Mary F.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (02) : 175 - 182
  • [2] Delayed cytogenetic and major molecular responses associated to increased BMI at baseline in chronic myeloid leukemia patients treated with imatinib
    Breccia, Massimo
    Loglisci, Giuseppina
    Salaroli, Adriano
    Serrao, Alessandra
    Mancini, Marco
    Diverio, Daniela
    Latagliata, Roberto
    Alimena, Giuliana
    [J]. CANCER LETTERS, 2013, 333 (01) : 32 - 35
  • [3] Adiponectin as a biomarker linking obesity and adiposopathy to hematologic malignancies
    Dalamaga, Maria
    Christodoulatos, Gerasimos S.
    [J]. HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2015, 23 (01) : 5 - 20
  • [4] SOME SPECULATIONS ON THE MYELOPROLIFERATIVE SYNDROMES
    DAMESHEK, W
    [J]. BLOOD, 1951, 6 (04) : 372 - 375
  • [5] Stability of variables associated with the metabolic syndrome from adolescence to adulthood: The Aerobics Center Longitudinal Study
    Eisenmann, JC
    Welk, GJ
    Wickel, EE
    Blair, SN
    [J]. AMERICAN JOURNAL OF HUMAN BIOLOGY, 2004, 16 (06) : 690 - 696
  • [6] Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications - a review
    Grygiel-Gorniak, Bogna
    [J]. NUTRITION JOURNAL, 2014, 13
  • [7] The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries
    Hoffmann, V. S.
    Baccarani, M.
    Hasford, J.
    Lindoerfer, D.
    Burgstaller, S.
    Sertic, D.
    Costeas, P.
    Mayer, J.
    Indrak, K.
    Everaus, H.
    Koskenvesa, P.
    Guilhot, J.
    Schubert-Fritschle, G.
    Castagnetti, F.
    Di Raimondo, F.
    Lejniece, S.
    Griskevicius, L.
    Thielen, N.
    Sacha, T.
    Hellmann, A.
    Turkina, A. G.
    Zaritskey, A.
    Bogdanovic, A.
    Sninska, Z.
    Zupan, I.
    Steegmann, J-L
    Simonsson, B.
    Clark, R. E.
    Covelli, A.
    Guidi, G.
    Hehlmann, R.
    [J]. LEUKEMIA, 2015, 29 (06) : 1336 - 1343
  • [8] Israel Central Bureau of Statistics, 2009, CHAR CLASS LOC AUTH
  • [9] JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms
    Jones, Amy V.
    Chase, Andrew
    Silver, Richard T.
    Oscier, David
    Zoi, Katerina
    Wang, Y. Lynn
    Cario, Holger
    Pahl, Heike L.
    Collins, Andrew
    Reiter, Andreas
    Grand, Francis
    Cross, Nicholas C. P.
    [J]. NATURE GENETICS, 2009, 41 (04) : 446 - 449
  • [10] Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24 577 first-degree relatives of 11 039 patients with myeloproliferative neoplasms in Sweden
    Landgren, Ola
    Goldin, Lynn R.
    Kristinsson, Sigurdur Y.
    Helgadottir, Elin A.
    Samuelsson, Jan
    Bjorkholm, Magnus
    [J]. BLOOD, 2008, 112 (06) : 2199 - 2204